How many intravitreal antibiotic injections can be administered within a 7‑day period?

Intravitreal Antibiotics: Frequency Over 7 Days

For therapeutic treatment of endophthalmitis, intravitreal antibiotics can be administered multiple times within a 7-day period, with repeat injections typically given every 2-4 weeks for fomivirsen, or as clinically indicated based on treatment response—though most cases require only a single initial injection followed by close monitoring.

Treatment Context: Therapeutic vs. Prophylactic Use

The frequency of intravitreal antibiotic administration depends critically on whether you're treating active infection or preventing it:

For Active Endophthalmitis (Therapeutic)

• Initial injection is standard: One intravitreal antibiotic injection at diagnosis 1
• Repeat injections are uncommon but possible: Based on clinical response and culture results
• The IDSA candidiasis guidelines specify fomivirsen can be repeated every 2-4 weeks for CMV retinitis 1, establishing precedent for serial intravitreal injections
• Timing matters critically: Treatment within 2 hours of presentation yields significantly better visual outcomes 2

For Prophylaxis (Routine IVI Procedures)

• No antibiotic prophylaxis is recommended for routine intravitreal injections 3
• Multiple 2019 surgical prophylaxis guidelines consistently state "No ABP" for intravitreal injections

Practical Treatment Algorithm

When treating endophthalmitis:

1. Day 0: Immediate intravitreal antibiotics (vancomycin 1 mg/0.1 mL + either amikacin 0.4 mg/0.1 mL or ceftazidime 2.25 mg/0.1 mL) 4

2. Days 1-3: Clinical monitoring for response

   • Improving: Continue systemic/topical therapy only
   • Worsening: Consider repeat injection or vitrectomy

3. Beyond Day 3: Repeat intravitreal injection only if:

   • Inadequate clinical response
   • Persistent positive cultures
   • Progressive vitritis despite initial treatment

4. Duration: Treatment continues at least 4-6 weeks total (systemic/topical), with final duration based on lesion resolution 1

Critical Safety Considerations

Toxicity risks limit frequency:

• Amikacin carries macular toxicity risk, particularly in incompletely vitrectomized eyes 5
• Multiple injections increase cumulative retinal exposure
• Each injection carries ~0.05% endophthalmitis risk 6

Alternative to repeated injections:

• Early vitrectomy with single intravitreal antibiotic injection may be more effective than multiple injections 7
• Immediate vitrectomy within 6 hours showed excellent visual recovery without requiring repeat injections

Common Pitfall to Avoid

Do not confuse prophylactic and therapeutic indications. The evidence clearly shows no benefit to prophylactic intravitreal antibiotics for routine anti-VEGF injections, despite the theoretical appeal. The 2019 guidelines across multiple surgical specialties uniformly recommend against this practice 3.

Practical answer: While there's no absolute maximum number specified in guidelines, most endophthalmitis cases resolve with 1-2 intravitreal antibiotic injections over a week, with the second injection reserved for inadequate response. More than 2-3 injections in 7 days would be exceptional and suggest need for surgical intervention (vitrectomy) rather than additional injections.